Live tape
Top 8, mentions 7d7,946MRNA2,171 mentions▲ +0.09NVDA1,495 mentions▲ +0.06GOOGL1,069 mentions▲ +0.05META896 mentions▲ +0.05WMT648 mentions+0.02SNDK600 mentions▲ +0.07QQQ557 mentions▲ +0.08SPY510 mentions▲ +0.04

Equity · Healthcare

VVOS

Vivos Therapeutics, Inc. · NasdaqCM

$0.42 +2.29% 1D Finazon · prior-day close · Jul 17, 2026
Price · Chart
Our own end-of-day closes 36 sessions
$1.2 $0.4 27 May 17 Jul

The line runs $0.66 on 27 May through $0.42 on 17 July, on a scale from $0.4 to $1.2. Days the market did not trade hold the previous close, flat.

Track this symbol on TradingView

The chart above plots the price of VVOS over the range selected — one day to the full history — drawn by TradingView from their own data. Our own licensed end-of-day series holds 36 sessions over that window: $0.66 on 27 May 2026 through $0.42 on 17 July 2026.

Market cap $8.4M
Avg volume 116.4K

Finazon · prior-day close · valuation computed from SEC EDGAR filings · as of Aug 25, 2026

Filings 4 sets

VVOS reported financials

SEC EDGAR XBRL

VVOS reported revenue of $17.4M for the fiscal year ended 31 Dec 2025. Net income over the same period was −$21.2M.

Figure Reported Period
Revenue $17.4M 31 Dec 2025 fiscal year
Net income −$21.2M 31 Dec 2025 fiscal year
Diluted EPS −$2.07 31 Dec 2025 fiscal year
Total assets $24.1M 30 Jun 2026 at period end
Total equity −$3.8M 30 Jun 2026 at period end

Source: SEC EDGAR XBRL company facts · latest period ended 30 Jun 2026

VVOS earnings

SEC EDGAR
Date Period EPS Revenue
30 Jun 2026 Q2 2026 $-0.31 $5M
31 Mar 2026 Q1 2026 $-0.52 $5M
31 Dec 2025 FY 2025 $-2.07 $17M
30 Sep 2025 Q3 2025 $-0.49 $7M
30 Jun 2025 Q2 2025 $-0.55 $4M
31 Mar 2025 Q1 2025 $-0.45 $3M
31 Dec 2024 FY 2024 $-2.22 $15M
30 Sep 2024 Q3 2024 $-0.40 $4M

Next report no date announced in SEC filings yet

Reported figures & scheduled dates · SEC EDGAR filings

VVOS institutional holders

SEC Form 13F

0 of the 45 institutional funds we track reported a VVOS position for the quarter ended 31 Dec 2025; the latest of those filings landed 12 Feb 2026.

Fund Action Shares Value
Renaissance Technologies Exited

Source: SEC EDGAR 13F filings

VVOS fails-to-deliver

SEC CNS data

On 31 Jul 2026, 4,800 shares of VVOS failed to deliver (about $2K).

Settlement date Shares failed Notional % of shares out
31 Jul 2026 4,800 $2K 0.024%
29 Jul 2026 3,571 $1K 0.018%
24 Jul 2026 1,454 $567 0.007%
21 Jul 2026 1,692 $694 0.008%
20 Jul 2026 3,317 $1K 0.016%
17 Jul 2026 7,326 $3K 0.036%
16 Jul 2026 579 $237 0.003%

Source: SEC fails-to-deliver (CNS) data